NeoBLAST, a phase 2/3 Canadian trial, tests whether active surveillance can safely replace surgery/radiation in MIBC patients with complete response to neoadjuvant therapy.
Marie-Pier St-Laurent, MD, FRCSC
Advertisement
St-Laurent is a urologic oncologist at the University of British Columbia in Vancouver, Canada.
Articles by Marie-Pier St-Laurent, MD, FRCSC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Prostate Cancer Awareness Month: Prostate cancer screening in 2026
2
Preparing urology practices for the next era of specialty care
3
Meeting men where they are: A urologist's case for community outreach
4
Enrollment goal met in phase 3 study of 68Ga-PSMA-PET in pre-biopsy setting
5